155 related articles for article (PubMed ID: 16341803)
1. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
[TBL] [Abstract][Full Text] [Related]
2. BRCA1/2 genetic testing in the community setting.
Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
4. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
5. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
[TBL] [Abstract][Full Text] [Related]
6. Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing.
Doughty Rice C; Ruschman JG; Martin LJ; Manders JB; Miller E
Fam Cancer; 2010 Jun; 9(2):203-12. PubMed ID: 20473602
[TBL] [Abstract][Full Text] [Related]
7. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
[TBL] [Abstract][Full Text] [Related]
8. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
Baumanis L; Evans JP; Callanan N; Susswein LR
J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
[TBL] [Abstract][Full Text] [Related]
9. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.
Patrick-Miller L; Egleston BL; Daly M; Stevens E; Fetzer D; Forman A; Bealin L; Rybak C; Peterson C; Corbman M; Bradbury AR
Patient Educ Couns; 2013 Dec; 93(3):413-9. PubMed ID: 24075727
[TBL] [Abstract][Full Text] [Related]
10. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
11. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
13. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
[TBL] [Abstract][Full Text] [Related]
14. Referral and experience with genetic testing among women with early onset breast cancer.
Brown KL; Hutchison R; Zinberg RE; McGovern MM
Genet Test; 2005; 9(4):301-5. PubMed ID: 16379543
[TBL] [Abstract][Full Text] [Related]
15. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
16. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
Peshkin BN; Schwartz MD; Isaacs C; Hughes C; Main D; Lerman C
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1115-8. PubMed ID: 12376518
[TBL] [Abstract][Full Text] [Related]
17. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
Bluman LG; Rimer BK; Berry DA; Borstelmann N; Iglehart JD; Regan K; Schildkraut J; Winer EP
J Clin Oncol; 1999 Mar; 17(3):1040-6. PubMed ID: 10071299
[TBL] [Abstract][Full Text] [Related]
18. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
Calderon-Margalit R; Paltiel O
Int J Cancer; 2004 Nov; 112(3):357-64. PubMed ID: 15382059
[TBL] [Abstract][Full Text] [Related]
19. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.
Metcalfe KA; Snyder C; Seidel J; Hanna D; Lynch HT; Narod S
Fam Cancer; 2005; 4(2):97-103. PubMed ID: 15951959
[TBL] [Abstract][Full Text] [Related]
20. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
